Genetic alterations involved in NAFLD pathobiology, include polymorphisms in the patatin-like phospholipase domain-containing 3 (PNPLA3) and the transmembrane 6 superfamily member 2 (TM6SF2) genes. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.